Vantage logo

Sanofi seeks to build on COPD win

Full Dupixent data confirm the drug’s blockbuster potential in the lung disease, but the French drug maker is thinking even bigger.

Vantage logo

Arrowhead delivers in the lung

Early clinical data with an inhaled RNA interference candidate look promising, but there is still much to prove.